Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
XTSX:IPA
Price:
6.5
CAD
0.78%
Market Closed
Market Cap:
CA$161.4m
Cash Flow Statement
Cash Flow Statement
Immunoprecise Antibodies Ltd
Immunoprecise Antibodies Ltd
Currency: CAD
| Jan-2022 | ||
|---|---|---|
| Operating Cash Flow | ||
| Net Income |
(19)
|
|
| Depreciation & Amortization |
7
|
|
| Change in Deffered Taxes |
1
|
|
| Other Non-Cash Items |
6
|
|
| Cash Taxes Paid |
2
|
|
| Cash Interest Paid |
0
|
|
| Change in Working Capital |
(2)
|
|
| Cash from Operating Activities |
(9)
N/A
|
|
| Investing Cash Flow | ||
| Capital Expenditures |
(2)
|
|
| Other Items |
(1)
|
|
| Cash from Investing Activities |
(4)
N/A
|
|
| Financing Cash Flow | ||
| Net Issuance of Common Stock |
45
|
|
| Net Issuance of Debt |
(1)
|
|
| Cash from Financing Activities |
43
N/A
|
|
| Change in Cash | ||
| Effect of Foreign Exchange Rates |
(1)
|
|
| Net Change in Cash |
30
N/A
|
|
| Free Cash Flow | ||
| Free Cash Flow |
(11)
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
